Hereditary spherocytosis diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
Amar Morani (talk | contribs) No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
=== Diagnostic Criteria === | |||
* The diagnosis of hereditary spherocytosis can be based on the physical examination, complete red cell count, recticulocyte count, medical history and specific tests, preferentially, the EMA (eosin-5-maleimide binding) test and AGLT (acidified glycerol lysis time).<ref name="GuittonGarçon2008">{{cite journal|last1=Guitton|first1=C.|last2=Garçon|first2=L.|last3=Cynober|first3=T.|last4=Gauthier|first4=F.|last5=Tchernia|first5=G.|last6=Delaunay|first6=J.|last7=Leblanc|first7=T.|last8=Thuret|first8=I.|last9=Bader-Meunier|first9=B.|title=Sphérocytose héréditaire : recommandations pour le diagnostic et la prise en charge chez l’enfant|journal=Archives de Pédiatrie|volume=15|issue=9|year=2008|pages=1464–1473|issn=0929693X|doi=10.1016/j.arcped.2008.04.023}}</ref><ref>{{Cite journal | |||
| author = [[Sayeeda Huq]], [[Mark A. C. Pietroni]], [[Hafizur Rahman]] & [[Mohammad Tariqul Alam]] | |||
| title = Hereditary spherocytosis | |||
| journal = [[Journal of health, population, and nutrition]] | |||
| volume = 28 | |||
| issue = 1 | |||
| pages = 107–109 | |||
| year = 2010 | |||
| month = February | |||
| pmid = 20214092 | |||
}}</ref> | |||
* The diagnosis can be made at any age, including the neonatal period from day of birth.<ref>{{Cite journal | |||
| author = [[Yuki Tateno]], [[Ryoji Suzuki]] & [[Yukihiro Kitamura]] | |||
| title = Previously undiagnosed hereditary spherocytosis in a patient with jaundice and pyelonephritis: a case report | |||
| journal = [[Journal of medical case reports]] | |||
| volume = 10 | |||
| issue = 1 | |||
| pages = 337 | |||
| year = 2016 | |||
| month = December | |||
| doi = 10.1186/s13256-016-1144-8 | |||
| pmid = 27906107 | |||
}}</ref> | |||
* The diagnostic guidelines of hereditary spherocytosis from the British Committee for Standards in hematology do not recommend any additional tests for patients with classical clinical features and laboratory data. | |||
* The eosin-5-maleimide (EMA) binding test has high sensitivity (92–93%) and specificity (99%) for hereditary spherocytosis, although a positive test can also be obtained in patients affected by related conditions, such as congenital dyserythropoietic anemia type II (CDA II) | |||
* Other tests, such as the osmotic fragility (OF) test, acidified glycerol lysis test (AGLT) and the pink test, exhibit lower sensitivity compared to the EMA test (68%, 61% and 91%, respectively).<ref>{{Cite journal | |||
| author = [[Immacolata Andolfo]], [[Roberta Russo]], [[Antonella Gambale]] & [[Achille Iolascon]] | |||
| title = New insights on hereditary erythrocyte membrane defects | |||
| journal = [[Haematologica]] | |||
| volume = 101 | |||
| issue = 11 | |||
| pages = 1284–1294 | |||
| year = 2016 | |||
| month = November | |||
| doi = 10.3324/haematol.2016.142463 | |||
| pmid = 27756835 | |||
}}</ref> | |||
* Ektacytometry is a highly sensitive test of membrane deformability. | |||
{| class="wikitable" | |||
|+ | |||
Simple Diagnostic Criteria to evoke the Diagnosis of Hereditary Spherocytosis | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Clinical Parameters}} | |||
| pallor, splenomegaly, inconstant jaundice | |||
|- | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Biological paraneters & erythrocyte indices}} | |||
| dec Hb, inc MCHC, inc %hyperdense cells, inc reticulocytes | |||
|- | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Blood smear}} | |||
| Spherocytes (may be absent) | |||
|- | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Signs of hemolysis}} | |||
| inc free bilirubin, dec haptoglobin, inc reticulocytes | |||
|- | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Erythrocyte coombs test}} | |||
| negative | |||
|} | |||
{| class="wikitable" | |||
|+ | |||
Specific Biological Examinations for the Diagnosis of Hereditary Spherocytosis | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Tests}} | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Principle/feasibility}} | |||
! style="background: #4479BA; width: 150px;" | {{fontcolor|#FFF|Sensitivity/Specificity}} | |||
|- | |||
| Osmotic resistance | |||
| hemolysis test/routime examination | |||
| 66%/low | |||
|- | |||
| Pink test | |||
| hemolysis test/simple test time-out test <3 hours | |||
| 96%/79-94% | |||
|- | |||
| AGLT | |||
| Hemolysis test time of test >3 hours | |||
| 81%/95% | |||
|- | |||
| Ektacytometry in osmolar gradient | |||
| study of deformity of RBCs single laboratory in France test execution time:24 hours | |||
| reference exam | |||
|- | |||
| Flow cytometry | |||
| labeling of RBCs with eosin 5 maleimide/not available on routine basis test run time >48 h | |||
| Being evaluated | |||
|} | |||
# Newly diagnosed patients with a family history of HS, typical clinical features and laboratory investigations (spherocytes, raised mean corpuscular haemoglobin concentration [MCHC], increase in reticulocytes) do not require any additional tests (grade 1 recommendation, grade A evidence). | # Newly diagnosed patients with a family history of HS, typical clinical features and laboratory investigations (spherocytes, raised mean corpuscular haemoglobin concentration [MCHC], increase in reticulocytes) do not require any additional tests (grade 1 recommendation, grade A evidence). | ||
# If the diagnosis is equivocal, a screening test with high predictive value for HS is helpful. The recommended screening tests are the cryohaemolysis test and EMA binding (grade 1 recommendation, grade A evidence). (Confirmation). | # If the diagnosis is equivocal, a screening test with high predictive value for HS is helpful. The recommended screening tests are the cryohaemolysis test and EMA binding (grade 1 recommendation, grade A evidence). (Confirmation). | ||
# Gel electrophoresis analysis of erythrocyte membranes is the method of choice for diagnosis of atypical cases.{{cite web |url=https://doi.org/10.1111/j.1365-2141.2011.08921.x+ |title=Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update - Bolton‐Maggs - 2012 - British Journal of Haematology - Wiley Online Library |format= |work= |accessdate=}} | # Gel electrophoresis analysis of erythrocyte membranes is the method of choice for diagnosis of atypical cases.{{cite web |url=https://doi.org/10.1111/j.1365-2141.2011.08921.x+ |title=Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update - Bolton‐Maggs - 2012 - British Journal of Haematology - Wiley Online Library |format= |work= |accessdate=}} |
Revision as of 15:21, 28 November 2018
Diagnostic Criteria
- The diagnosis of hereditary spherocytosis can be based on the physical examination, complete red cell count, recticulocyte count, medical history and specific tests, preferentially, the EMA (eosin-5-maleimide binding) test and AGLT (acidified glycerol lysis time).[1][2]
- The diagnosis can be made at any age, including the neonatal period from day of birth.[3]
- The diagnostic guidelines of hereditary spherocytosis from the British Committee for Standards in hematology do not recommend any additional tests for patients with classical clinical features and laboratory data.
- The eosin-5-maleimide (EMA) binding test has high sensitivity (92–93%) and specificity (99%) for hereditary spherocytosis, although a positive test can also be obtained in patients affected by related conditions, such as congenital dyserythropoietic anemia type II (CDA II)
- Other tests, such as the osmotic fragility (OF) test, acidified glycerol lysis test (AGLT) and the pink test, exhibit lower sensitivity compared to the EMA test (68%, 61% and 91%, respectively).[4]
- Ektacytometry is a highly sensitive test of membrane deformability.
Clinical Parameters | pallor, splenomegaly, inconstant jaundice |
---|---|
Biological paraneters & erythrocyte indices | dec Hb, inc MCHC, inc %hyperdense cells, inc reticulocytes |
Blood smear | Spherocytes (may be absent) |
Signs of hemolysis | inc free bilirubin, dec haptoglobin, inc reticulocytes |
Erythrocyte coombs test | negative |
Tests | Principle/feasibility | Sensitivity/Specificity |
---|---|---|
Osmotic resistance | hemolysis test/routime examination | 66%/low |
Pink test | hemolysis test/simple test time-out test <3 hours | 96%/79-94% |
AGLT | Hemolysis test time of test >3 hours | 81%/95% |
Ektacytometry in osmolar gradient | study of deformity of RBCs single laboratory in France test execution time:24 hours | reference exam |
Flow cytometry | labeling of RBCs with eosin 5 maleimide/not available on routine basis test run time >48 h | Being evaluated |
- Newly diagnosed patients with a family history of HS, typical clinical features and laboratory investigations (spherocytes, raised mean corpuscular haemoglobin concentration [MCHC], increase in reticulocytes) do not require any additional tests (grade 1 recommendation, grade A evidence).
- If the diagnosis is equivocal, a screening test with high predictive value for HS is helpful. The recommended screening tests are the cryohaemolysis test and EMA binding (grade 1 recommendation, grade A evidence). (Confirmation).
- Gel electrophoresis analysis of erythrocyte membranes is the method of choice for diagnosis of atypical cases."Guidelines for the diagnosis and management of hereditary spherocytosis – 2011 update - Bolton‐Maggs - 2012 - British Journal of Haematology - Wiley Online Library".
- ↑ Guitton, C.; Garçon, L.; Cynober, T.; Gauthier, F.; Tchernia, G.; Delaunay, J.; Leblanc, T.; Thuret, I.; Bader-Meunier, B. (2008). "Sphérocytose héréditaire : recommandations pour le diagnostic et la prise en charge chez l'enfant". Archives de Pédiatrie. 15 (9): 1464–1473. doi:10.1016/j.arcped.2008.04.023. ISSN 0929-693X.
- ↑ Sayeeda Huq, Mark A. C. Pietroni, Hafizur Rahman & Mohammad Tariqul Alam (2010). "Hereditary spherocytosis". Journal of health, population, and nutrition. 28 (1): 107–109. PMID 20214092. Unknown parameter
|month=
ignored (help) - ↑ Yuki Tateno, Ryoji Suzuki & Yukihiro Kitamura (2016). "Previously undiagnosed hereditary spherocytosis in a patient with jaundice and pyelonephritis: a case report". Journal of medical case reports. 10 (1): 337. doi:10.1186/s13256-016-1144-8. PMID 27906107. Unknown parameter
|month=
ignored (help) - ↑ Immacolata Andolfo, Roberta Russo, Antonella Gambale & Achille Iolascon (2016). "New insights on hereditary erythrocyte membrane defects". Haematologica. 101 (11): 1284–1294. doi:10.3324/haematol.2016.142463. PMID 27756835. Unknown parameter
|month=
ignored (help)